You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 292 No. 23, December 15, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Medical News & Perspectives
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Nutritional and Metabolic Disorders
 •Metabolic Diseases
 •Genetics
 •Genetic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Mitochondrial Defects May Play Role in the Metabolic Syndrome

Tracy Hampton, PhD

JAMA. 2004;292:2823-2824.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

While the metabolic syndrome has been thrust into the spotlight because of the obesity epidemic, it is clear that the condition is not simply caused by lifestyle habits such as overeating and inactivity. Genetic components likely play a role, and scientists have now identified a potential genetic culprit for some individuals with the condition.

MITOCHONDRIAL MUTATION

An estimated 47 million people in the United States have the metabolic syndrome, which is associated with the development of diabetes and heart disease. Factors characteristic of the syndrome include

  • Central obesity (excessive fat tissue in and around the abdomen)
  • Atherogenic dyslipidemia (high triglycerides and low HDL cholesterol)
  • Raised blood pressure (130/85 mm Hg or higher)
  • Insulin resistance (with or without glucose intolerance)
  • Prothrombotic state (eg, high fibrinogen or plasminogen activator inhibitor in the blood)
  • Proinflammatory state

Hypomagnesemia is another possible associated finding. In addition, patients with hypertension and/or hypercholesterolemia often have hypomagnesemia . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.